Novo Nordisk A/S (NVO)
126.16
-2.48
(-1.93%)
USD |
NYSE |
Apr 24, 16:00
124.89
-1.27
(-1.01%)
After-Hours: 20:00
Novo Nordisk Price: 126.16 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 127.16 | 127.32 | 125.35 | 126.16 | 3.092M |
| Apr 23, 2024 | 126.57 | 128.76 | 126.34 | 128.64 | 3.704M |
| Apr 22, 2024 | 122.59 | 126.25 | 122.57 | 125.26 | 3.798M |
| Apr 19, 2024 | 123.48 | 124.54 | 122.46 | 122.71 | 5.183M |
| Apr 18, 2024 | 123.30 | 124.10 | 122.51 | 122.75 | 2.841M |
| Apr 17, 2024 | 124.95 | 125.21 | 123.26 | 124.53 | 3.075M |
| Apr 16, 2024 | 123.07 | 124.25 | 121.79 | 123.45 | 3.044M |
| Apr 15, 2024 | 125.81 | 126.05 | 123.52 | 123.90 | 2.897M |
| Apr 12, 2024 | 126.74 | 127.06 | 124.35 | 124.51 | 3.343M |
| Apr 11, 2024 | 125.48 | 125.88 | 124.13 | 125.40 | 2.419M |
| Apr 10, 2024 | 123.39 | 125.26 | 123.24 | 124.93 | 3.025M |
| Apr 09, 2024 | 126.18 | 126.74 | 124.22 | 124.86 | 3.215M |
| Apr 08, 2024 | 127.00 | 127.63 | 125.99 | 127.46 | 3.017M |
| Apr 05, 2024 | 124.67 | 126.17 | 124.60 | 125.86 | 4.998M |
| Apr 04, 2024 | 126.90 | 127.48 | 123.77 | 123.96 | 4.007M |
| Apr 03, 2024 | 125.38 | 128.13 | 125.38 | 126.99 | 3.616M |
| Apr 02, 2024 | 125.05 | 126.68 | 124.08 | 126.46 | 4.322M |
| Apr 01, 2024 | 129.11 | 129.11 | 127.15 | 127.55 | 3.065M |
| Mar 28, 2024 | 128.39 | 130.16 | 127.79 | 128.40 | 3.657M |
| Mar 27, 2024 | 128.33 | 128.62 | 127.29 | 128.05 | 3.941M |
| Mar 26, 2024 | 130.10 | 130.16 | 128.44 | 129.41 | 4.218M |
| Mar 25, 2024 | 129.00 | 130.25 | 128.71 | 129.05 | 3.320M |
| Mar 22, 2024 | 129.22 | 129.49 | 128.11 | 128.76 | 3.229M |
| Mar 21, 2024 | 129.00 | 131.07 | 127.11 | 129.83 | 6.549M |
| Mar 20, 2024 | 131.15 | 131.43 | 128.83 | 130.36 | 4.404M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.40
Minimum
May 16 2019
135.92
Maximum
Mar 07 2024
54.33
Average
50.38
Median
Jan 12 2022
Price Benchmarks
| Amgen Inc | 273.01 |
| AstraZeneca PLC | 71.20 |
| Sanofi SA | 46.61 |
| Viking Therapeutics Inc | 65.07 |
| Evaxion Biotech AS | 4.13 |
Price Related Metrics
| PE Ratio | 46.70 |
| PS Ratio | 16.83 |
| PEG Ratio | 0.8327 |
| Price to Book Value | 35.59 |
| Price to Free Cash Flow | 55.81 |
| Earnings Yield | 2.14% |
| Market Cap | 562.84B |
| PEGY Ratio | 0.8172 |
| Operating PE Ratio | 38.10 |
| Normalized PE Ratio | 46.70 |